Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Maxi-K channel modulators from Bristol-Myers Squibb

Nov. 25, 1996

Lilly claims structurally novel NK1 antagonists

Nov. 25, 1996

NeoTherapeutics' lead small molecule advances toward clinical trials in AD

Nov. 22, 1996

Guilford's orally active neuroimmunophilin highly effective in animal models of Parkinson's disease

Nov. 22, 1996

Lamotrigine now available in France

Nov. 22, 1996

Antiparkinsonian skin patch enters pivotal phase II trial

Nov. 22, 1996

Approval recommended for Elan's gel formulation of diazepam

Nov. 21, 1996

SIBIA Neurosciences reports preclinical results with NAChR-selective compounds

Nov. 21, 1996

NIH to conduct clinical trial of Ampalex in AD

Nov. 21, 1996

First pivotal trial for panic disorder Rx

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...